Patents by Inventor Luwei Zhao

Luwei Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LOW-DOSE CELECOXIB PREPARATION
    Publication number: 20220395514
    Abstract: The disclosed invention relates to a low-dose celecoxib oral formulation, and a preparation method therefor, which is characterized in that the strength of the formulation is 60-90% of the original strength of the commercial celecoxib product, and the celecoxib formulation with such reduced strength is bioequivalent to the commercial celecoxib product. The celecoxib formulation can be used for the treatment of mild to moderate pain and mild to moderate chronic pain.
    Type: Application
    Filed: June 26, 2019
    Publication date: December 15, 2022
    Inventors: Hong Sun, Tao Wang, Yan Hu, Fenrong Luo, Jinxiang Zhan, Yungen Xie, Jiawei Qi, Luwei Zhao
  • COMPOSITIONS COMPRISING MELOXICAM-CYCLODEXTRIN INCLUSION COMPLEXES AND METHODS OF TREATING ACUTE PAIN
    Publication number: 20170216305
    Abstract: The present invention is directed to a method of administering a meloxicam formulation to a mammalian subject in need thereof including: orally administering to the subject an oral solid dosage form including an amorphous meloxicam-cyclodextrin inclusion complex, where administering the amorphous meloxicam-cyclodextrin inclusion complex results in the subject achieving a Tmax not greater than about 3.0 hours.
    Type: Application
    Filed: September 29, 2015
    Publication date: August 3, 2017
    Applicant: Arissa Pharma Ltd.
    Inventors: Hong Sun, Yan Hu, Yansheng Chen, Luwei Zhao